Jeil Pharmaceutical Co (XKRX:271980) Total Liabilities : ₩306,383 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Jeil Pharmaceutical Co Total Liabilities?

Jeil Pharmaceutical Co's Total Liabilities for the quarter that ended in Dec. 2024 was ₩306,383 Mil.

Jeil Pharmaceutical Co's quarterly Total Liabilities increased from Jun. 2024 (₩304,516.36 Mil) to Sep. 2024 (₩309,351.93 Mil) but then declined from Sep. 2024 (₩309,351.93 Mil) to Dec. 2024 (₩306,382.84 Mil).

Jeil Pharmaceutical Co's annual Total Liabilities increased from Dec. 2022 (₩301,294.32 Mil) to Dec. 2023 (₩330,294.13 Mil) but then declined from Dec. 2023 (₩330,294.13 Mil) to Dec. 2024 (₩306,382.84 Mil).

Jeil Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Jeil Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharmaceutical Co Total Liabilities Chart

Jeil Pharmaceutical Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

237,184.01

259,139.22

301,294.32

330,294.13

306,382.84

Jeil Pharmaceutical Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															330,294.13	333,926.73	304,516.36	309,351.93	306,382.84

Jeil Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Jeil Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	291690.184	+	(2724.588	+	197.01100000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	11771.058	+	0)
	=	306,383

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	525699.687	-	219316.846
	=	306,383

Jeil Pharmaceutical Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	291690.184	+	(2724.588	+	197.01100000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	11771.058	+	0)
	=	306,383

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	525699.687	-	219316.846
	=	306,383

Jeil Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Jeil Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharmaceutical Co Ltd (XKRX:271980) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

343, Sapyeong-daero, Seocho-gu, Seoul, KOR, 06543

Website

https://www.jeilpharm.co.kr

Jeil Pharmaceutical Co Ltd is engaged in maufacturing and distribution of pharmaceutical products. The company's products include antibiotics, anti-inflammatory painkillers, hepatitis remedies, duodenum ulcer treatments, and anticancer drugs.

Jeil Pharmaceutical Co Headlines

No Headlines